Updated logo UPDATED Back to feed
build deploy Ars Technica October 16, 2026

RFK Jr. proposes FDA look the other way on unproven peptides, report says

RFK Jr. proposes FDA look the other way on unproven peptides, report says
AI Summary

Under Health Secretary Robert F. Kennedy Jr., the Food and Drug Administration is moving forward with plans to ease access to unproven peptide drugs that are popular among members of Kennedy's Make America Healthy Again movement—despite FDA staff scientists finding that the drugs have not been sufficiently studied to establish safety and efficacy and may cause harms. The FDA submitted an "Interim Access Policy" on peptides for review by the White House, according to a filing notice posted on an

0 views
Read full article
Read it on Updated — Tech News. Ahead of the Curve.
Discussion
Sign in to join the discussion.
Loading comments…